These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6127315)

  • 21. Fimbrial hemagglutinin in stationary and shake cultures of Bordetella pertussis.
    Arai H; Munoz JJ
    Infect Immun; 1979 Aug; 25(2):764-7. PubMed ID: 39897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on a method for the assay of antibody to Bordetella pertussis fimbrial hemagglutinin after inoculation with pertussis HA vaccine (author's transl)].
    Murase Y
    Kansenshogaku Zasshi; 1981 Jul; 55(7):511-23. PubMed ID: 6120200
    [No Abstract]   [Full Text] [Related]  

  • 23. Morphology of cells and hemagglutinogens of Bordetella species: resolution of substructural units in fimbriae of Bordetella pertussis.
    Blom J; Hansen GA; Poulsen FM
    Infect Immun; 1983 Oct; 42(1):308-17. PubMed ID: 6137457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fimbrial typing of Bordetello pertussis isolates: agglutination with polyclonal and monoclonal antisera.
    Guiso N; von Konig CH; Becker C; Hallander H
    J Clin Microbiol; 2001 Apr; 39(4):1684-5. PubMed ID: 11354036
    [No Abstract]   [Full Text] [Related]  

  • 25. Serotyping Bordetella pertussis strains.
    Robinson A; Ashworth LA; Irons LI
    Vaccine; 1989 Dec; 7(6):491-4. PubMed ID: 2575308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against intranasal infection of mice with Bordetella pertussis.
    Robinson A; Ashworth LA; Baskerville A; Irons LI
    Dev Biol Stand; 1985; 61():165-72. PubMed ID: 2872102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agglutinogens and fimbriae of Bordetella pertussis.
    Ashworth LA; Robinson A; Funnell S; Gorringe AR; Irons LI; Seabrook RN
    Tokai J Exp Clin Med; 1988; 13 Suppl():203-10. PubMed ID: 2908520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential.
    Scheller EV; Cotter PA
    Pathog Dis; 2015 Nov; 73(8):ftv079. PubMed ID: 26416077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-lived respiratory immune response to filamentous hemagglutinin following Bordetella pertussis infection.
    Amsbaugh DF; Li ZM; Shahin RD
    Infect Immun; 1993 Apr; 61(4):1447-52. PubMed ID: 8454349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective activities in mice of monoclonal antibodies against pertussis toxin.
    Sato H; Sato Y
    Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of fimbriae from "Bordetella" species.
    Gaastra W; van der Heide HG; ter Avest A; Hamers A; Wellinder KG; van der Zeijst BA; Mooi FR
    Ann Sclavo Collana Monogr; 1986; 3(1-2):299-306. PubMed ID: 2892510
    [No Abstract]   [Full Text] [Related]  

  • 32. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
    Cherry JD; Gornbein J; Heininger U; Stehr K
    Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities.
    Halperin SA; Barreto L; Eastwood BJ; Law B; Roberts EA
    Arch Pediatr Adolesc Med; 1994 Nov; 148(11):1220-4. PubMed ID: 7921131
    [No Abstract]   [Full Text] [Related]  

  • 34. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
    Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
    Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of hydromechanical stress on cellular antigens of Bordetella pertussis.
    Rodriguez ME; Hozbor DF; Yantorno OM
    J Ind Microbiol; 1996 Jul; 17(1):53-5. PubMed ID: 8987690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of antigenic domains on the major subunits of Bordetella pertussis serotype 2 and 3 fimbriae.
    Pearce AM; Seabrook RN; Irons LI; Ashworth LA; Atkinson T; Robinson A
    Microbiology (Reading); 1994 Jan; 140 ( Pt 1)():205-11. PubMed ID: 7512870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.
    Kimura A; Mountzouros KT; Relman DA; Falkow S; Cowell JL
    Infect Immun; 1990 Jan; 58(1):7-16. PubMed ID: 2294058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines.
    Barkoff AM; Guiso N; Guillot S; Xing D; Markey K; Berbers G; Mertsola J; He Q
    J Immunol Methods; 2014 Jun; 408():142-8. PubMed ID: 24925807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents.
    Hodder SL; Cherry JD; Mortimer EA; Ford AB; Gornbein J; Papp K
    Clin Infect Dis; 2000 Jul; 31(1):7-14. PubMed ID: 10913389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.
    Pittman M
    Rev Infect Dis; 1979; 1(3):401-12. PubMed ID: 233166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.